In short
Ceftolozane is an emerging antibiotic that shows great potential in treating serious bacterial infections, particularly those caused by drug-resistant organisms. This article summarizes key findings from clinical trials investigating the use of ceftolozane, often combined with tazobactam, for various conditions including pneumonia, cystic fibrosis exacerbations, and infections in critically ill patients.
At a glance
- Drug Name
- Ceftolozane (often combined with Tazobactam)
- Drug Class
- Cephalosporin antibiotic
- Main Target
- Multidrug-resistant Pseudomonas aeruginosa infections
- Administration
- Intravenous infusion, typically every 8 hours
- Key Indications
- Hospital-acquired pneumonia, ventilator-associated pneumonia, complicated urinary tract infections, intra-abdominal infections
- Special Populations
- Being studied in cystic fibrosis patients and critically ill patients
- Safety Profile
- Generally well-tolerated; common side effects include nausea, diarrhea, headache
- Ongoing Research
- Optimal dosing, effectiveness against resistant bacteria, use in special populations (e.g., cystic fibrosis)
What is Ceftolozane?
Ceftolozane is a new type of antibiotic that is often combined with another drug called tazobactam. This combination is known as ceftolozane-tazobactam or ceftolozane/tazobactam. It's also sold under the brand name Zerbaxa. Ceftolozane belongs to a class of antibiotics called cephalosporins, which are used to treat various bacterial infections.
What Conditions Does Ceftolozane Treat?
Ceftolozane-tazobactam is used to treat several types of serious bacterial infections, including:
- Complicated urinary tract infections (cUTI): These are infections in the urinary system that are more difficult to treat than typical urinary tract infections.
- Complicated intra-abdominal infections (cIAI): These are infections that occur inside the abdomen and are more severe or complex.
- Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP): These are types of lung infections that patients can get while in the hospital, especially if they're on a breathing machine.
- Infections caused by Pseudomonas aeruginosa: This is a type of bacteria that can cause severe infections and is often resistant to many antibiotics.
How Does Ceftolozane Work?
Ceftolozane works by stopping bacteria from building their cell walls, which they need to survive and multiply. When combined with tazobactam, it becomes even more effective. Tazobactam helps protect ceftolozane from being broken down by certain enzymes that some bacteria produce to resist antibiotics.
One of the key benefits of ceftolozane-tazobactam is its effectiveness against bacteria that have become resistant to other antibiotics. It's particularly useful against a type of bacteria called Pseudomonas aeruginosa, which is known for being hard to treat.
How is Ceftolozane Administered?
Ceftolozane-tazobactam is given as an intravenous (IV) infusion, which means it's delivered directly into your bloodstream through a vein. The typical dose for adults is 1.5 grams (1 gram of ceftolozane and 0.5 grams of tazobactam) given every 8 hours. For more severe infections like hospital-acquired pneumonia, the dose may be increased to 3 grams every 8 hours.
The infusion usually takes about an hour. The length of treatment can vary depending on the type and severity of the infection, but it's typically between 4 to 14 days.
Effectiveness of Ceftolozane
Clinical trials have shown that ceftolozane-tazobactam is effective in treating various types of infections. It has been particularly successful in treating infections caused by bacteria that are resistant to other antibiotics.
For example, in patients with cystic fibrosis who often suffer from lung infections caused by resistant bacteria, ceftolozane-tazobactam has shown promising results. It's also been effective in treating complicated urinary tract and intra-abdominal infections caused by certain types of resistant bacteria.
Ongoing Research and Clinical Trials
Researchers are continually studying ceftolozane-tazobactam to better understand its effectiveness and safety in different patient groups and for various types of infections. Some ongoing areas of research include:
- Its use in treating infections in patients with blood cancers.
- Its effectiveness against certain types of resistant bacteria in critically ill patients.
- How well it works compared to other antibiotics for bloodstream infections.
- How the drug moves through the body in different patient groups, such as those with burns or brain injuries.
Potential Side Effects
Like all medications, ceftolozane-tazobactam can cause side effects. Common side effects may include:
- Nausea
- Diarrhea
- Headache
- Fever
- Constipation
More serious side effects, although rare, can include severe allergic reactions, kidney problems, or a type of diarrhea caused by C. difficile bacteria. It's important to tell your doctor about any side effects you experience.
Remember, your doctor has prescribed this medication because they believe the benefits outweigh the potential risks. Always follow your doctor's instructions and don't hesitate to ask questions if you have concerns about your treatment.